Metformin is a widely used drug of T2DM, and its antidiabetic characteristics should be inhibiting hepatic gluconeogenesis and improving insulin sensitivity in peripheral tissues (Adak, Samadi, Unal, & Sabuncuoglu, 2018). The gene discussed is INS; the disease is type 2 diabetes mellitus.